These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients.
    Author: Ställberg B, Janson C, Lisspers K, Johansson G, Gutzwiller FS, Mezzi K, Bjerregaard BK, Kejs AMT, Jorgensen L, Larsson K.
    Journal: NPJ Prim Care Respir Med; 2020 Oct 20; 30(1):47. PubMed ID: 33082331.
    Abstract:
    This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and the 5-year cumulative incidence rate per 100,000 person years was 1506.9. The yearly incidence rate per 100,000 person years ranged from 850 to 1919. Use of ICS especially at a high dose in patients with COPD was related to an increased risk of T2DM.
    [Abstract] [Full Text] [Related] [New Search]